Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Ziprasidone Treatment Report
What is Ziprasidone?

Ziprasidone is used to treat the symptoms of schizophrenia. It is also used to treat episodes of mania or mixed episodes in people with bipolar disorders. It is in a class of medical called atypical antipsychotics.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Emotional lability 3 1
Possible bipolar II 3 1
Other 3 1
General health 2 0
schizoaffective disorder 1 0
pre-antidepressant 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 50%
Moderate
0 0%
Mild
0 0%
None
1 50%

Most commonly reported side effects

Hand tremor
1 50%
Sleepiness
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  40 mg daily 60 mg daily 80 mg daily 120 mg daily 160 mg daily 240 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Ziprasidone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 67% Side effects too severe: 67%
Doctor's advice
1 33% Doctor's advice: 33%

See all 3 patients who’ve stopped taking Ziprasidone

Currently Taking Ziprasidone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
1
2
2

Stopped Taking Ziprasidone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 50%
Somewhat
0 0%
A little
0 0%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 50%
$25-49
0 0%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 24, 2009.